Affymetrix (Santa Clara, California) Control Program Advances Association Studies And Saves Researchers Time And Money; World’s Largest Population Genetics Control Resource Will Provide Free Public Access To Genotype Data On More Than 12,000 Samples

SANTA CLARA, Calif.--(BUSINESS WIRE)--Aug. 2, 2006--Affymetrix Inc. (NASDAQ:AFFX) announced today that it is collaborating with leading researchers around the world as part of the Affymetrix Control Program. The program will provide free, public access to control cohort data for whole-genome association studies using Affymetrix GeneChip(R) genotyping arrays. Participating organizations include GlaxoSmithKline, the National Genome Research Network (NGFN) in Germany, Erasmus MC in the Netherlands, the Karolinska Institute in Sweden, the Centre National de Genotypage in France and the Wellcome Trust Case Control Consortium (WTCCC) in the UK.